190 related articles for article (PubMed ID: 19322210)
21. Molecular pathogenesis of myelodysplastic syndromes with deletion 5q.
Lee JH; List A; Sallman DA
Eur J Haematol; 2019 Mar; 102(3):203-209. PubMed ID: 30578738
[TBL] [Abstract][Full Text] [Related]
22. Molecular analysis of the 5q- chromosome.
Nagarajan L
Leuk Lymphoma; 1995 May; 17(5-6):361-6. PubMed ID: 7549826
[TBL] [Abstract][Full Text] [Related]
23. Gene expression profiling of CD34+ cells in patients with the 5q- syndrome.
Boultwood J; Pellagatti A; Cattan H; Lawrie CH; Giagounidis A; Malcovati L; Della Porta MG; Jädersten M; Killick S; Fidler C; Cazzola M; Hellström-Lindberg E; Wainscoat JS
Br J Haematol; 2007 Nov; 139(4):578-89. PubMed ID: 17916100
[TBL] [Abstract][Full Text] [Related]
24. Loss of both CSF1R (FMS) alleles in patients with myelodysplasia and a chromosome 5 deletion.
Boultwood J; Rack K; Kelly S; Madden J; Sakaguchi AY; Wang LM; Oscier DG; Buckle VJ; Wainscoat JS
Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6176-80. PubMed ID: 1829836
[TBL] [Abstract][Full Text] [Related]
25. Van-den Berghe's 5q- syndrome in 2008.
Mohamedali A; Mufti GJ
Br J Haematol; 2009 Jan; 144(2):157-68. PubMed ID: 19016715
[TBL] [Abstract][Full Text] [Related]
26. Deletions of chromosome 5 in malignant myeloid disorders.
Le Beau MM
Cancer Surv; 1992; 15():143-59. PubMed ID: 1451109
[TBL] [Abstract][Full Text] [Related]
27. Familial MDS with 5q- abnormality.
Grimwade DJ; Stephenson J; De Silva C; Dalton RG; Mufti GJ
Br J Haematol; 1993 Jul; 84(3):536-8. PubMed ID: 8217806
[TBL] [Abstract][Full Text] [Related]
28. Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes.
Pellagatti A; Hellström-Lindberg E; Giagounidis A; Perry J; Malcovati L; Della Porta MG; Jädersten M; Killick S; Fidler C; Cazzola M; Wainscoat JS; Boultwood J
Br J Haematol; 2008 Jul; 142(1):57-64. PubMed ID: 18477045
[TBL] [Abstract][Full Text] [Related]
29. Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS.
Schneider RK; Ademà V; Heckl D; Järås M; Mallo M; Lord AM; Chu LP; McConkey ME; Kramann R; Mullally A; Bejar R; Solé F; Ebert BL
Cancer Cell; 2014 Oct; 26(4):509-20. PubMed ID: 25242043
[TBL] [Abstract][Full Text] [Related]
30. Recurrent genetic defects on chromosome 5q in myeloid neoplasms.
Hosono N; Makishima H; Mahfouz R; Przychodzen B; Yoshida K; Jerez A; LaFramboise T; Polprasert C; Clemente MJ; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Sanada M; Cui E; Verma AK; McDevitt MA; List AF; Saunthararajah Y; Sekeres MA; Boultwood J; Ogawa S; Maciejewski JP
Oncotarget; 2017 Jan; 8(4):6483-6495. PubMed ID: 28031539
[TBL] [Abstract][Full Text] [Related]
31. Molecular Pathogenesis of MDS.
Look AT
Hematology Am Soc Hematol Educ Program; 2005; ():156-60. PubMed ID: 16304374
[TBL] [Abstract][Full Text] [Related]
32. 5q-: pathogenetic importance of the common deleted region and clinical consequences of the entire deleted segment.
Pedersen B
Anticancer Res; 1993; 13(5C):1913-6. PubMed ID: 8267400
[TBL] [Abstract][Full Text] [Related]
33. A new recurrent translocation, t(5;11)(q35;p15.5), associated with del(5q) in childhood acute myeloid leukemia. The UK Cancer Cytogenetics Group (UKCCG).
Jaju RJ; Haas OA; Neat M; Harbott J; Saha V; Boultwood J; Brown JM; Pirc-Danoewinata H; Krings BW; Müller U; Morris SW; Wainscoat JS; Kearney L
Blood; 1999 Jul; 94(2):773-80. PubMed ID: 10397745
[TBL] [Abstract][Full Text] [Related]
34. [Genetic defects of chromosome 5q and 7q in myeloid neoplasms].
Hosono N
Rinsho Ketsueki; 2019; 60(7):800-809. PubMed ID: 31391370
[TBL] [Abstract][Full Text] [Related]
35. Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion.
Sebaa A; Ades L; Baran-Marzack F; Mozziconacci MJ; Penther D; Dobbelstein S; Stamatoullas A; Récher C; Prebet T; Moulessehoul S; Fenaux P; Eclache V
Genes Chromosomes Cancer; 2012 Dec; 51(12):1086-92. PubMed ID: 22933333
[TBL] [Abstract][Full Text] [Related]
36. Clinical management of myelodysplastic syndromes with interstitial deletion of chromosome 5q.
Nimer SD
J Clin Oncol; 2006 Jun; 24(16):2576-82. PubMed ID: 16735711
[TBL] [Abstract][Full Text] [Related]
37. Myelodysplastic syndromes associated with interstitial deletion of chromosome 5q: clinicopathologic correlations and new insights from the pre-lenalidomide era.
Holtan SG; Santana-Davila R; Dewald GW; Khetterling RP; Knudson RA; Hoyer JD; Chen D; Hanson CA; Porrata L; Tefferi A; Steensma DP
Am J Hematol; 2008 Sep; 83(9):708-13. PubMed ID: 18634051
[TBL] [Abstract][Full Text] [Related]
38. Chromosomal deletions in myelodysplasia.
Boultwood J; Fidler C
Leuk Lymphoma; 1995 Mar; 17(1-2):71-8. PubMed ID: 7773164
[TBL] [Abstract][Full Text] [Related]
39. Integrated genomic analysis implicates haploinsufficiency of multiple chromosome 5q31.2 genes in de novo myelodysplastic syndromes pathogenesis.
Graubert TA; Payton MA; Shao J; Walgren RA; Monahan RS; Frater JL; Walshauser MA; Martin MG; Kasai Y; Walter MJ
PLoS One; 2009; 4(2):e4583. PubMed ID: 19240791
[TBL] [Abstract][Full Text] [Related]
40. CSNK1A1 mutations and isolated del(5q) abnormality in myelodysplastic syndrome: a retrospective mutational analysis.
Smith AE; Kulasekararaj AG; Jiang J; Mian S; Mohamedali A; Gaken J; Ireland R; Czepulkowski B; Best S; Mufti GJ
Lancet Haematol; 2015 May; 2(5):e212-21. PubMed ID: 26688096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
